Lab
Rapid Results Diagnostics LLC
Rapid Results Diagnostics LLC was paid $53K by Medicaid between Apr 2021 and Aug 2022, across 7 billing codes. Its largest line is 87426, Infectious agent antigen detection, SARS-CoV-2 (COVID-19) — 71% of everything it billed.
33Billing provider infoRAPID RESULTS DIAGNOSTICS LLC
BENTONVILLE, AR 72712
BENTONVILLE, AR 72712
33aNPI1144819632assigned 01/11/2021
33bProvider typeClinical Medical Laboratory
28Total paid$53K
24GClaims4,240
24DCodes billed7
24AFirst – last monthApr 2021 – Aug 2022
Compared with peers
Next to other Clinical Medical Laboratory providers in Arkansas
Rank by total paid#13 of 24
Median peer was paid$53K
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 3,336 | $36K | |
| 2022 | 904 | $17K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 71% | 1,821 | 1,051 | $38K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 18% | 204 | 102 | $9K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 7.3% | 57 | 39 | $4K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 3.6% | 150 | 106 | $2K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,656 | 1,001 | $140.76 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 141 | 75 | $25.00 |
| 99072 | 0% | 211 | 92 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDURRANCE, JOSHUA (PRESIDENT)